↓ Skip to main content

Globotriaosylsphingosine (lyso-Gb3) might not be a reliable marker for monitoring the long-term therapeutic outcomes of enzyme replacement therapy for late-onset Fabry patients with the Chinese…

Overview of attention for article published in Orphanet Journal of Rare Diseases, July 2014
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (69th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (53rd percentile)

Mentioned by

policy
1 policy source
twitter
1 X user

Citations

dimensions_citation
32 Dimensions

Readers on

mendeley
54 Mendeley